SlideShare a Scribd company logo
SHOCK IN CHILDREN
-Dr.Apoorva.E
PG,DCMS
• “ ACUTE CIRCULATORY FAILURE “
with inadequate or inappropriately
distributed tissue perfusion
resulting in generalized cellular
hypoxia
• Body’s inability to deliver adequate oxygen to
meet the metabolic demands of the tissues.
• Initially compensated
• Continued presence of an inciting trigger +
body’s exaggerated response
lead to progression of shock
if untreated,irreversible tissue injury
irreversible shock
CLASSIFICATION
• 5 major types of shock
1.HYPOVOLEMIC
2.CARDIOGENIC
3.OBSTRUCTIVE
4.DISTRIBUTIVE
5.SEPTIC
HYPOVOLEMIC SHOCK
• Characterized by fluid loss ( internal / external )
• Decreased preload
Water/electrolyte plasma blood
loss loss loss
CARDIOGENIC SHOCK
• Poor myocardial contractility leading to cardiac
pump failure
• Due to :
CHD
Myocarditis
Cardiomyopathies
Arrhythmias
OBSTRUCTIVE SHOCK
• Decreased cardiac output secondary to restriction
of all cardiac chambers
• Due to :
Tension pneumothorax
Pericardial tamponade
Pulmonary embolism
Anterior mediastinal masses
Coarctation of aorta
DISTRIBUTIVE SHOCK
• Caused by inadequate vasomotor tone
Capillary leak
Maldistribution of fluid into interstitium
• Post-spinal cord or brainstem injury
Anaphylaxis
Poisonings
SEPTIC SHOCK
• Complex interaction of
distributive,cardiogenic and hypovolemic
shock
• Bacterial/Viral/Fungal
Hypovolemic shock – blood VOLUME
problem
Cardiogenic shock - blood PUMP
problem
Distributive shock – blood VESSEL
problem
PATHOPHYSIOLOGY
COMPENSATORY MECHANISMS
• >> Heart rate
• >> Stroke volume
• >> Vascular smooth muscle tone
• >> O2 extraction from the blood
• Redistributing blood flow to
brain,kidneys,adrenals and heart at the
expense of skin and GIT
To compensate for the metabolic acidosis,
- >> RR with >>CO2 elimination
- Renal excretion of hydrogen ions
- Retention of bicarbonate ions
To maintain intravascular volume,
- Sodium regulation through RAAS
- ADH secretion
- Cortisol and catecholamine synthesis and release
CLINICAL MANIFESTATIONS
• Tachycardia
• Tachypnoea
• Decreased urine output
• Poor peripheral pulses
• Alteration of mental status
• Low BP
COMPENSATED
• Confusion
• Tachycardia
• Normal or mild tachypnoea
• >> CFT
• U/o-adequate
• BP normal
UNCOMPENSATED
• Drowsiness
• Marked tachycardia
• Tachypnoea and acidosis
• Very slow CFT
• Oliguria/Anuria
• Hypotension
HYPOTENSION FORMULA
Ages – 1 to 10 years
Hypotension is defined as SBP
< 70mmHg + [age in years X 2] mmHg
IRREVERSIBLE
• Child is unresponsive
• Bradycardia
• Apnoea
• Cold cyanotic skin
• Anuria
• Unrecordable BP
DIAGNOSIS
• Thorough history and physical exam
• Lab findings : thrombocytopenia
prolonged PT and apTT
reduced serum fibrinogen level
>> fibrin split products
anemia
neutrophilia
left shift of leukocytes
electrolyte disturbances
HYPOVOLEMIC SHOCK
<< intravascular volume
<< venous return and preload
<< decreased ventricular filling
<< decreased stroke volume
<< CO
<< tissue perfusion
PATHOPHYSIOLOGY
ASSESSMENT OF FLUID LOSS
TREATMENT
1.Assess airway
2.Administer oxygen
3.Establish IV access
4.Fluid bolus of 20ml/kg isotonic fluid given
5.Continue fluid boluses (maximum of 3) until
perfusion improves or hepatomegaly develops
6.In case of shock refractory to fluids,start
inotrope (dopamine)
GOAL – RESTORE CIRCULATING VOLUME AND TISSUE
PERFUSION , CORRECT THE CAUSE
CARDIOGENIC SHOCK
Impaired pumping ability of LV
Inadequate systolic emptying of LV
>>LV filling pressure << Stroke volume
>>Left atrial pressure << CO
>>Pulmonary capillary pressure
Pulmonary interstitial and intralveolar edema
PATHOPHYSIOLOGY
CLINICAL PRESENTATION
• Tachycardia
• Low volume pulse
• Cold clammy extremities
• >>CFT
• Pulmonary edema,Crackles,RD,Tachypnoea
• Jugular venous distension
• Hepatomegaly
• Hypotension
• Oliguria,changes in mental status
TREATMENT
GOAL - >> CO, treat reversible causes, <<
myocardial workload
1.Assess airway , administer
oxygen/mechanical ventilation
2.IV access
3.Inotropic agents,vasoactive drugs to >>
cardiac contractility and to decrease
systemic vascular resistance
4.Cautious administration of fluids
(5-10ml/kg boluses over longer time)
5. Morphine to decrease preload and
anxiety
6.Vasodilators for afterload reduction
7.Short acting beta blockers for refractory
tachycardia
OBSTRUCTIVE SHOCK
PATHOPHYSIOLOGY
Physical obstruction to blood flow
<< CO
<< Tissue perfusion
Compensatory >> in systemic vascular resistance
CLINICAL PRESENTATION
• Muffled heart sounds
• Distended neck veins
• Pulsus paradoxus ( << in SBP by
more than 10mmHg on inspiration )
• Signs of right heart failure plus
cyanosis,tachycardia,hypotension
PERICARDIAL
EFFUSION
PULMONARY
EMBOLISM
TREATMENT
• Pericardial drainage in case of
pericardial effusion
• Immediate needle decompression then
thoracostomy for chest tube in case of
tension pneumothorax
• Anticoagulants or embolectomy for
pulmonary embolism
DISTRIBUTIVE SHOCK
Maldistribution of blood flow
Some tissues inadequately Some tissues
perfused over perfused
(splanchnic circulation) (skeletal muscle,
skin)
PATHOPHYSIOLOGY
<< Systemic vascular >> Systemic vascular
resistance & resistance &
>> blood flow to skin << blood flow to skin
Warm extremities, Cold extremities,
bounding peripheral weak pulses
pulses
WARM SHOCK COLD SHOCK
CLINICAL PRESENTATION
• Tachypnoea without increased work of
breathing
• Hypotension/Normotension
• Bounding pulses/Weak pulses
• Brisk/delayed CFT
• Warm flushed skin/cold pale skin
TREATMENT
1. ANAPHYLACTIC SHOCK –
Airway,
IV epinephrine,
Antihistaminics,
Corticosteroids,
Withdrawal of Ag ,
Vasopressors,Inotropes,
Cautious fluid administration
2. NEUROGENIC SHOCK –
Cautious fluid administration,
Vasopressors,Inotropes,
Correct hypothermia,
Treat bradycardia with atropine,
Observe and prevent DVT (due to
peripheral pooling of blood)
SEPTIC SHOCK
PATHOPHYSIOLOGY
DEFINITIONS
SIRS
• Requires 2 of the following 4 features to be
present:
o Temperature >38.5° or <36.0° C
o Tachypnea >2SD ABOVE NORMAL FOR AGE
o Tachycardia  >2SD ABOVE NORMAL FOR AGE
o WBC ELEVATED OR DEPRESSED FOR AGE/>10%
IMMATURE NEUTROPHILS
INFECTION
• Suspected or proven infection or a clinical
syndrome associated with high probability
of infection
SEPSIS
• SIRS plus a suspected or proven infection
SEVERE SEPSIS
• Sepsis plus organ dysfunction,hypoperfusion
or hypotension
(including but not limited to lactic
acidosis,oliguria,acute mental status changes)
Identifying Acute Organ Dysfunction as a
Marker of Severe Sepsis
Tachycardia
Hypotension
 CVP
 PAOP
Jaundice
 Enzymes
 Albumin
 PT
Altered
Consciousness
Confusion
Psychosis
Tachypnea
PaO2 <70 mm Hg
SaO2 <90%
PaO2/FiO2 300
Oliguria
Anuria
 Creatinine
 Platelets
 PT/APTT
 Protein C
 D-dimer
MODS
• Presence of altered organ function such that
homeostasis cannot be maintained without
medical intervention
WORK UP
• Laboratory studies
o CBP
o Comprehensive chemistry panel (serum elec,abg,BUN,serum
creat,GRBS,LFT,serum lactate)
o Coagulation studies
o Blood & urine cultures
• Imaging studies
o Chest radiography
o Abdominal radiography
o Others according to the suspected cause.
DRAW SAMPLE FOR BLOOD C/S
AND START EMPERICAL
ANTIBIOTIC
•Antibiotics should be administered within the first hour of
recognition of septic shock
•Selection of antibiotic agents is empirically based on
an assessment of patient's immunity
the potential source of infection
the most likely responsible organisms.
•Antibiotic choice must be broad spectrum, covering gram-positive,
gram-negative, and anaerobic bacteria when the source is unknown
•Regimen for septic shock of unknown cause is
oGentamicin
o3rd generation cephalosporin
o if pseudomonas is suspected,ceftazidime
• Vancomycin must be added if resistant
staphylococci or enterococci are suspected.
• If there is an abdominal source, a drug effective
against anaerobes should be included
“metronidazole”
• Antibiotics are continued for at least 5 days after
shock resolves and evidence of infection subsides
• Abscesses must be drained and necrotic tissues
(eg, infarcted bowel) surgically excised.
DRUGS USED IN
SHOCK
1.Dopamine
-ionotrope at low dose
- peripheral vasoconstriction at
>10mcg/kg/min
- 3-20mcg/kg/min
-arrythmia at higher doses
2. Epinephrine
- >> HR and >> cardiac contractility
- Potent vasoconstrictor
- 0.05 – 3 mcg/kg/min
- << renal perfusion at higher doses,arrythmia at
higher doses
3. Norepinephrine
- Potent vasoconstrictor
- No significant effect on cardiac contractility
- 0.05 to 1.5 mcg/kg/min
4. Dobutamine
- >> cardiac contractility
- Peripheral vasodilator
- 1-10 mcg/kg/min
5.Phenylephrine
-potent vasoconstrictor
-0.5 to 2 mcg/kg/min
->> O2 consumption
-can cause sudden hypertension
Drug Indication Dose MOA Principal actions
Dopamine Renal perfusion 2-5 mcg/kg/min Dopaminergic Renal a. dilation
hypotension 5-10 mcg/kg/min 1 &
dopaminergic
+ inotrope
Hypotension >10 mcg/kg/min 1 vasoconstriction
Dobutamine Cardiogenic shock 2.5-25 mcg/kg/min Selective 1 + inotrope
Norepinephrine Hypotension 2-4 mcg/min 1 & 1 Vasoconstriction
Phenylephrine Hypotension 40-180 mcg/min Selective 1 Vasoconstriction
THANK YOU

More Related Content

What's hot

Heart failure in children 2021
Heart failure in children 2021Heart failure in children 2021
Heart failure in children 2021
Imran Iqbal
 
Perinatal asphyxia
Perinatal asphyxiaPerinatal asphyxia
Perinatal asphyxiaVarsha Shah
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizures
CSN Vittal
 
Hypoglycemia in children
Hypoglycemia in childrenHypoglycemia in children
Hypoglycemia in children
Sujay Bhirud
 
Dka management in children
Dka management in childrenDka management in children
Dka management in children
Abdulmoein AlAgha
 
Failure to thrive
Failure to thriveFailure to thrive
Failure to thrive
Dr,Kaushik Barot
 
Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia  Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia
mandar haval
 
Neonatal examination
Neonatal examinationNeonatal examination
Neonatal examination
. .
 
Diarrhoea in children
Diarrhoea in childrenDiarrhoea in children
Diarrhoea in children
Virendra Hindustani
 
Status Asthmaticus In Children
Status Asthmaticus In ChildrenStatus Asthmaticus In Children
Status Asthmaticus In ChildrenDang Thanh Tuan
 
Approach to a child with Hepatosplenomegaly
Approach to a child with HepatosplenomegalyApproach to a child with Hepatosplenomegaly
Approach to a child with HepatosplenomegalySunil Agrawal
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in children
giridharkv
 
Congestive heart failure revised
Congestive heart failure revisedCongestive heart failure revised
Congestive heart failure revised
pediatricsmgmcri
 
shock in children.pptx
shock in children.pptxshock in children.pptx
shock in children.pptx
Ankit Kumar
 
Hypothyroidism in children 2021
Hypothyroidism in children 2021Hypothyroidism in children 2021
Hypothyroidism in children 2021
Imran Iqbal
 
Bronchial asthma in children
Bronchial asthma in children Bronchial asthma in children
Bronchial asthma in children
Azad Haleem
 
Pediatric poisoning .ppt
Pediatric poisoning .pptPediatric poisoning .ppt
Pediatric poisoning .ppt
Ramin Nazari M.D
 

What's hot (20)

Heart failure in children 2021
Heart failure in children 2021Heart failure in children 2021
Heart failure in children 2021
 
Paediatric septic-shock
Paediatric septic-shockPaediatric septic-shock
Paediatric septic-shock
 
Perinatal asphyxia
Perinatal asphyxiaPerinatal asphyxia
Perinatal asphyxia
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizures
 
Hypoglycemia in children
Hypoglycemia in childrenHypoglycemia in children
Hypoglycemia in children
 
Dka management in children
Dka management in childrenDka management in children
Dka management in children
 
Respiratory distress in newborn
Respiratory distress in newbornRespiratory distress in newborn
Respiratory distress in newborn
 
Failure to thrive
Failure to thriveFailure to thrive
Failure to thrive
 
SHORT STATURE
SHORT STATURESHORT STATURE
SHORT STATURE
 
Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia  Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia
 
Neonatal examination
Neonatal examinationNeonatal examination
Neonatal examination
 
Diarrhoea in children
Diarrhoea in childrenDiarrhoea in children
Diarrhoea in children
 
Status Asthmaticus In Children
Status Asthmaticus In ChildrenStatus Asthmaticus In Children
Status Asthmaticus In Children
 
Approach to a child with Hepatosplenomegaly
Approach to a child with HepatosplenomegalyApproach to a child with Hepatosplenomegaly
Approach to a child with Hepatosplenomegaly
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in children
 
Congestive heart failure revised
Congestive heart failure revisedCongestive heart failure revised
Congestive heart failure revised
 
shock in children.pptx
shock in children.pptxshock in children.pptx
shock in children.pptx
 
Hypothyroidism in children 2021
Hypothyroidism in children 2021Hypothyroidism in children 2021
Hypothyroidism in children 2021
 
Bronchial asthma in children
Bronchial asthma in children Bronchial asthma in children
Bronchial asthma in children
 
Pediatric poisoning .ppt
Pediatric poisoning .pptPediatric poisoning .ppt
Pediatric poisoning .ppt
 

Similar to Shock in children

Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
NooriMumash
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
DanishMandi
 
SHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.pptSHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.ppt
TbndkSamuelTesa
 
Shock
ShockShock
Shock
Upwork
 
Shock
ShockShock
SHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptxSHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptx
Dr. Adamu Ibrahim
 
Haemorrhage
HaemorrhageHaemorrhage
Haemorrhage
SakuntalaGiri1
 
hypovolemic shock.pdf
hypovolemic shock.pdfhypovolemic shock.pdf
hypovolemic shock.pdf
karna ram choudhary
 
Shock
ShockShock
Hemorrhage and shock
Hemorrhage and shockHemorrhage and shock
Hemorrhage and shock
Dr. Virshali Gupta
 
Multisystem inflammatory syndrome with covid 19 in pediatrics
Multisystem inflammatory syndrome with covid 19 in pediatricsMultisystem inflammatory syndrome with covid 19 in pediatrics
Multisystem inflammatory syndrome with covid 19 in pediatrics
Mounika Bhallam
 
SHOCK Assignment.pptx
SHOCK Assignment.pptxSHOCK Assignment.pptx
SHOCK Assignment.pptx
Leonard Otieno
 
Dengue in icu
Dengue in icuDengue in icu
Dengue in icu
Anupal Kahlon
 
hemorrhage and shock.pptx
hemorrhage and shock.pptxhemorrhage and shock.pptx
hemorrhage and shock.pptx
vanitha n
 
Shock
Shock Shock
13. SHOCK (2).pptx
13. SHOCK (2).pptx13. SHOCK (2).pptx
13. SHOCK (2).pptx
MwanjalukaWaluNkausu
 
SHOCK
SHOCKSHOCK
My shock overview
My shock overviewMy shock overview
My shock overview
Dr. Mohamed Maged Kharabish
 
Pals 2017 part 4
Pals 2017   part 4Pals 2017   part 4
Pals 2017 part 4
Sayed Ahmed
 
paediatric emergency.pptx
paediatric emergency.pptxpaediatric emergency.pptx
paediatric emergency.pptx
VijiM14
 

Similar to Shock in children (20)

Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
SHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.pptSHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.ppt
 
Shock
ShockShock
Shock
 
Shock
ShockShock
Shock
 
SHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptxSHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptx
 
Haemorrhage
HaemorrhageHaemorrhage
Haemorrhage
 
hypovolemic shock.pdf
hypovolemic shock.pdfhypovolemic shock.pdf
hypovolemic shock.pdf
 
Shock
ShockShock
Shock
 
Hemorrhage and shock
Hemorrhage and shockHemorrhage and shock
Hemorrhage and shock
 
Multisystem inflammatory syndrome with covid 19 in pediatrics
Multisystem inflammatory syndrome with covid 19 in pediatricsMultisystem inflammatory syndrome with covid 19 in pediatrics
Multisystem inflammatory syndrome with covid 19 in pediatrics
 
SHOCK Assignment.pptx
SHOCK Assignment.pptxSHOCK Assignment.pptx
SHOCK Assignment.pptx
 
Dengue in icu
Dengue in icuDengue in icu
Dengue in icu
 
hemorrhage and shock.pptx
hemorrhage and shock.pptxhemorrhage and shock.pptx
hemorrhage and shock.pptx
 
Shock
Shock Shock
Shock
 
13. SHOCK (2).pptx
13. SHOCK (2).pptx13. SHOCK (2).pptx
13. SHOCK (2).pptx
 
SHOCK
SHOCKSHOCK
SHOCK
 
My shock overview
My shock overviewMy shock overview
My shock overview
 
Pals 2017 part 4
Pals 2017   part 4Pals 2017   part 4
Pals 2017 part 4
 
paediatric emergency.pptx
paediatric emergency.pptxpaediatric emergency.pptx
paediatric emergency.pptx
 

More from apoorvaerukulla

NEONATAL RESUSCITATION PROGRAM/NALS - LATEST GUIDELINES 7TH EDITION
NEONATAL RESUSCITATION PROGRAM/NALS  - LATEST GUIDELINES 7TH EDITIONNEONATAL RESUSCITATION PROGRAM/NALS  - LATEST GUIDELINES 7TH EDITION
NEONATAL RESUSCITATION PROGRAM/NALS - LATEST GUIDELINES 7TH EDITION
apoorvaerukulla
 
Anemia & polycythemia in neonates
Anemia & polycythemia in neonatesAnemia & polycythemia in neonates
Anemia & polycythemia in neonates
apoorvaerukulla
 
Nephrotic syndrome- case definitons and treatment
Nephrotic syndrome- case definitons and treatmentNephrotic syndrome- case definitons and treatment
Nephrotic syndrome- case definitons and treatment
apoorvaerukulla
 
Foetal circulation,persistent pulmonary hypertension of the newborn
Foetal circulation,persistent pulmonary hypertension of the newbornFoetal circulation,persistent pulmonary hypertension of the newborn
Foetal circulation,persistent pulmonary hypertension of the newborn
apoorvaerukulla
 
Childhood obesity
Childhood obesityChildhood obesity
Childhood obesity
apoorvaerukulla
 
Case study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophyCase study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophy
apoorvaerukulla
 
acute flaccid paralysis and surveillance
acute flaccid paralysis and surveillanceacute flaccid paralysis and surveillance
acute flaccid paralysis and surveillance
apoorvaerukulla
 
APLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANT
APLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANTAPLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANT
APLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANT
apoorvaerukulla
 
DENGUE IN CHILDREN
DENGUE IN CHILDRENDENGUE IN CHILDREN
DENGUE IN CHILDREN
apoorvaerukulla
 
VITAMIN D AND HYPERPARATHYROIDISM
VITAMIN D AND HYPERPARATHYROIDISMVITAMIN D AND HYPERPARATHYROIDISM
VITAMIN D AND HYPERPARATHYROIDISM
apoorvaerukulla
 
DEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GIT
DEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GITDEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GIT
DEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GIT
apoorvaerukulla
 
FEVER OF UNKNOWN ORIGIN - PEDIATRICS
FEVER OF UNKNOWN ORIGIN - PEDIATRICSFEVER OF UNKNOWN ORIGIN - PEDIATRICS
FEVER OF UNKNOWN ORIGIN - PEDIATRICS
apoorvaerukulla
 
Bone mineral density (bmd) test
Bone mineral density (bmd) testBone mineral density (bmd) test
Bone mineral density (bmd) test
apoorvaerukulla
 
Arrhythmias in children
Arrhythmias in childrenArrhythmias in children
Arrhythmias in children
apoorvaerukulla
 

More from apoorvaerukulla (14)

NEONATAL RESUSCITATION PROGRAM/NALS - LATEST GUIDELINES 7TH EDITION
NEONATAL RESUSCITATION PROGRAM/NALS  - LATEST GUIDELINES 7TH EDITIONNEONATAL RESUSCITATION PROGRAM/NALS  - LATEST GUIDELINES 7TH EDITION
NEONATAL RESUSCITATION PROGRAM/NALS - LATEST GUIDELINES 7TH EDITION
 
Anemia & polycythemia in neonates
Anemia & polycythemia in neonatesAnemia & polycythemia in neonates
Anemia & polycythemia in neonates
 
Nephrotic syndrome- case definitons and treatment
Nephrotic syndrome- case definitons and treatmentNephrotic syndrome- case definitons and treatment
Nephrotic syndrome- case definitons and treatment
 
Foetal circulation,persistent pulmonary hypertension of the newborn
Foetal circulation,persistent pulmonary hypertension of the newbornFoetal circulation,persistent pulmonary hypertension of the newborn
Foetal circulation,persistent pulmonary hypertension of the newborn
 
Childhood obesity
Childhood obesityChildhood obesity
Childhood obesity
 
Case study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophyCase study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophy
 
acute flaccid paralysis and surveillance
acute flaccid paralysis and surveillanceacute flaccid paralysis and surveillance
acute flaccid paralysis and surveillance
 
APLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANT
APLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANTAPLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANT
APLASTIC ANEMIA, HEMATOPOIETIC STEM CELL TRANSPLANT
 
DENGUE IN CHILDREN
DENGUE IN CHILDRENDENGUE IN CHILDREN
DENGUE IN CHILDREN
 
VITAMIN D AND HYPERPARATHYROIDISM
VITAMIN D AND HYPERPARATHYROIDISMVITAMIN D AND HYPERPARATHYROIDISM
VITAMIN D AND HYPERPARATHYROIDISM
 
DEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GIT
DEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GITDEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GIT
DEVELOPMENT OF GIT AND CONGENITAL ANOMALIES OF GIT
 
FEVER OF UNKNOWN ORIGIN - PEDIATRICS
FEVER OF UNKNOWN ORIGIN - PEDIATRICSFEVER OF UNKNOWN ORIGIN - PEDIATRICS
FEVER OF UNKNOWN ORIGIN - PEDIATRICS
 
Bone mineral density (bmd) test
Bone mineral density (bmd) testBone mineral density (bmd) test
Bone mineral density (bmd) test
 
Arrhythmias in children
Arrhythmias in childrenArrhythmias in children
Arrhythmias in children
 

Recently uploaded

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 

Shock in children

  • 2. • “ ACUTE CIRCULATORY FAILURE “ with inadequate or inappropriately distributed tissue perfusion resulting in generalized cellular hypoxia
  • 3. • Body’s inability to deliver adequate oxygen to meet the metabolic demands of the tissues. • Initially compensated • Continued presence of an inciting trigger + body’s exaggerated response lead to progression of shock if untreated,irreversible tissue injury irreversible shock
  • 4.
  • 5. CLASSIFICATION • 5 major types of shock 1.HYPOVOLEMIC 2.CARDIOGENIC 3.OBSTRUCTIVE 4.DISTRIBUTIVE 5.SEPTIC
  • 6. HYPOVOLEMIC SHOCK • Characterized by fluid loss ( internal / external ) • Decreased preload Water/electrolyte plasma blood loss loss loss
  • 7. CARDIOGENIC SHOCK • Poor myocardial contractility leading to cardiac pump failure • Due to : CHD Myocarditis Cardiomyopathies Arrhythmias
  • 8. OBSTRUCTIVE SHOCK • Decreased cardiac output secondary to restriction of all cardiac chambers • Due to : Tension pneumothorax Pericardial tamponade Pulmonary embolism Anterior mediastinal masses Coarctation of aorta
  • 9. DISTRIBUTIVE SHOCK • Caused by inadequate vasomotor tone Capillary leak Maldistribution of fluid into interstitium • Post-spinal cord or brainstem injury Anaphylaxis Poisonings
  • 10. SEPTIC SHOCK • Complex interaction of distributive,cardiogenic and hypovolemic shock • Bacterial/Viral/Fungal
  • 11. Hypovolemic shock – blood VOLUME problem Cardiogenic shock - blood PUMP problem Distributive shock – blood VESSEL problem
  • 13. COMPENSATORY MECHANISMS • >> Heart rate • >> Stroke volume • >> Vascular smooth muscle tone • >> O2 extraction from the blood • Redistributing blood flow to brain,kidneys,adrenals and heart at the expense of skin and GIT
  • 14. To compensate for the metabolic acidosis, - >> RR with >>CO2 elimination - Renal excretion of hydrogen ions - Retention of bicarbonate ions To maintain intravascular volume, - Sodium regulation through RAAS - ADH secretion - Cortisol and catecholamine synthesis and release
  • 15. CLINICAL MANIFESTATIONS • Tachycardia • Tachypnoea • Decreased urine output • Poor peripheral pulses • Alteration of mental status • Low BP
  • 16. COMPENSATED • Confusion • Tachycardia • Normal or mild tachypnoea • >> CFT • U/o-adequate • BP normal
  • 17. UNCOMPENSATED • Drowsiness • Marked tachycardia • Tachypnoea and acidosis • Very slow CFT • Oliguria/Anuria • Hypotension
  • 18. HYPOTENSION FORMULA Ages – 1 to 10 years Hypotension is defined as SBP < 70mmHg + [age in years X 2] mmHg
  • 19. IRREVERSIBLE • Child is unresponsive • Bradycardia • Apnoea • Cold cyanotic skin • Anuria • Unrecordable BP
  • 20. DIAGNOSIS • Thorough history and physical exam • Lab findings : thrombocytopenia prolonged PT and apTT reduced serum fibrinogen level >> fibrin split products anemia neutrophilia left shift of leukocytes electrolyte disturbances
  • 21. HYPOVOLEMIC SHOCK << intravascular volume << venous return and preload << decreased ventricular filling << decreased stroke volume << CO << tissue perfusion PATHOPHYSIOLOGY
  • 23. TREATMENT 1.Assess airway 2.Administer oxygen 3.Establish IV access 4.Fluid bolus of 20ml/kg isotonic fluid given 5.Continue fluid boluses (maximum of 3) until perfusion improves or hepatomegaly develops 6.In case of shock refractory to fluids,start inotrope (dopamine) GOAL – RESTORE CIRCULATING VOLUME AND TISSUE PERFUSION , CORRECT THE CAUSE
  • 24. CARDIOGENIC SHOCK Impaired pumping ability of LV Inadequate systolic emptying of LV >>LV filling pressure << Stroke volume >>Left atrial pressure << CO >>Pulmonary capillary pressure Pulmonary interstitial and intralveolar edema PATHOPHYSIOLOGY
  • 25. CLINICAL PRESENTATION • Tachycardia • Low volume pulse • Cold clammy extremities • >>CFT • Pulmonary edema,Crackles,RD,Tachypnoea • Jugular venous distension • Hepatomegaly • Hypotension • Oliguria,changes in mental status
  • 26. TREATMENT GOAL - >> CO, treat reversible causes, << myocardial workload 1.Assess airway , administer oxygen/mechanical ventilation 2.IV access 3.Inotropic agents,vasoactive drugs to >> cardiac contractility and to decrease systemic vascular resistance
  • 27. 4.Cautious administration of fluids (5-10ml/kg boluses over longer time) 5. Morphine to decrease preload and anxiety 6.Vasodilators for afterload reduction 7.Short acting beta blockers for refractory tachycardia
  • 28. OBSTRUCTIVE SHOCK PATHOPHYSIOLOGY Physical obstruction to blood flow << CO << Tissue perfusion Compensatory >> in systemic vascular resistance
  • 29. CLINICAL PRESENTATION • Muffled heart sounds • Distended neck veins • Pulsus paradoxus ( << in SBP by more than 10mmHg on inspiration ) • Signs of right heart failure plus cyanosis,tachycardia,hypotension PERICARDIAL EFFUSION PULMONARY EMBOLISM
  • 30. TREATMENT • Pericardial drainage in case of pericardial effusion • Immediate needle decompression then thoracostomy for chest tube in case of tension pneumothorax • Anticoagulants or embolectomy for pulmonary embolism
  • 31. DISTRIBUTIVE SHOCK Maldistribution of blood flow Some tissues inadequately Some tissues perfused over perfused (splanchnic circulation) (skeletal muscle, skin) PATHOPHYSIOLOGY
  • 32. << Systemic vascular >> Systemic vascular resistance & resistance & >> blood flow to skin << blood flow to skin Warm extremities, Cold extremities, bounding peripheral weak pulses pulses WARM SHOCK COLD SHOCK
  • 33. CLINICAL PRESENTATION • Tachypnoea without increased work of breathing • Hypotension/Normotension • Bounding pulses/Weak pulses • Brisk/delayed CFT • Warm flushed skin/cold pale skin
  • 34. TREATMENT 1. ANAPHYLACTIC SHOCK – Airway, IV epinephrine, Antihistaminics, Corticosteroids, Withdrawal of Ag , Vasopressors,Inotropes, Cautious fluid administration
  • 35. 2. NEUROGENIC SHOCK – Cautious fluid administration, Vasopressors,Inotropes, Correct hypothermia, Treat bradycardia with atropine, Observe and prevent DVT (due to peripheral pooling of blood)
  • 37. DEFINITIONS SIRS • Requires 2 of the following 4 features to be present: o Temperature >38.5° or <36.0° C o Tachypnea >2SD ABOVE NORMAL FOR AGE o Tachycardia  >2SD ABOVE NORMAL FOR AGE o WBC ELEVATED OR DEPRESSED FOR AGE/>10% IMMATURE NEUTROPHILS
  • 38. INFECTION • Suspected or proven infection or a clinical syndrome associated with high probability of infection SEPSIS • SIRS plus a suspected or proven infection
  • 39. SEVERE SEPSIS • Sepsis plus organ dysfunction,hypoperfusion or hypotension (including but not limited to lactic acidosis,oliguria,acute mental status changes)
  • 40. Identifying Acute Organ Dysfunction as a Marker of Severe Sepsis Tachycardia Hypotension  CVP  PAOP Jaundice  Enzymes  Albumin  PT Altered Consciousness Confusion Psychosis Tachypnea PaO2 <70 mm Hg SaO2 <90% PaO2/FiO2 300 Oliguria Anuria  Creatinine  Platelets  PT/APTT  Protein C  D-dimer
  • 41.
  • 42. MODS • Presence of altered organ function such that homeostasis cannot be maintained without medical intervention
  • 43. WORK UP • Laboratory studies o CBP o Comprehensive chemistry panel (serum elec,abg,BUN,serum creat,GRBS,LFT,serum lactate) o Coagulation studies o Blood & urine cultures • Imaging studies o Chest radiography o Abdominal radiography o Others according to the suspected cause.
  • 44. DRAW SAMPLE FOR BLOOD C/S AND START EMPERICAL ANTIBIOTIC
  • 45. •Antibiotics should be administered within the first hour of recognition of septic shock •Selection of antibiotic agents is empirically based on an assessment of patient's immunity the potential source of infection the most likely responsible organisms. •Antibiotic choice must be broad spectrum, covering gram-positive, gram-negative, and anaerobic bacteria when the source is unknown •Regimen for septic shock of unknown cause is oGentamicin o3rd generation cephalosporin o if pseudomonas is suspected,ceftazidime
  • 46. • Vancomycin must be added if resistant staphylococci or enterococci are suspected. • If there is an abdominal source, a drug effective against anaerobes should be included “metronidazole” • Antibiotics are continued for at least 5 days after shock resolves and evidence of infection subsides • Abscesses must be drained and necrotic tissues (eg, infarcted bowel) surgically excised.
  • 48. 1.Dopamine -ionotrope at low dose - peripheral vasoconstriction at >10mcg/kg/min - 3-20mcg/kg/min -arrythmia at higher doses
  • 49. 2. Epinephrine - >> HR and >> cardiac contractility - Potent vasoconstrictor - 0.05 – 3 mcg/kg/min - << renal perfusion at higher doses,arrythmia at higher doses 3. Norepinephrine - Potent vasoconstrictor - No significant effect on cardiac contractility - 0.05 to 1.5 mcg/kg/min
  • 50. 4. Dobutamine - >> cardiac contractility - Peripheral vasodilator - 1-10 mcg/kg/min 5.Phenylephrine -potent vasoconstrictor -0.5 to 2 mcg/kg/min ->> O2 consumption -can cause sudden hypertension
  • 51.
  • 52. Drug Indication Dose MOA Principal actions Dopamine Renal perfusion 2-5 mcg/kg/min Dopaminergic Renal a. dilation hypotension 5-10 mcg/kg/min 1 & dopaminergic + inotrope Hypotension >10 mcg/kg/min 1 vasoconstriction Dobutamine Cardiogenic shock 2.5-25 mcg/kg/min Selective 1 + inotrope Norepinephrine Hypotension 2-4 mcg/min 1 & 1 Vasoconstriction Phenylephrine Hypotension 40-180 mcg/min Selective 1 Vasoconstriction
  • 53.
  • 54.
  • 55.